Cannabis Strategic Ventures (NUGS)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Cannabis Strategic Ventures Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2020 | -1.349M |
March 31, 2020 | -2.521M |
December 31, 2019 | -2.311M |
September 30, 2019 | -3.049M |
June 30, 2019 | -3.164M |
March 31, 2019 | -1.428M |
December 31, 2018 | -0.4864M |
September 30, 2018 | -0.4383M |
June 30, 2018 | -0.213M |
March 31, 2018 | -0.3255M |
December 31, 2017 | -0.1459M |
September 30, 2017 | -0.0332M |
Date | Value |
---|---|
June 30, 2017 | -0.0244M |
March 31, 2017 | -0.0044M |
December 31, 2016 | -0.0017M |
September 30, 2016 | -0.005M |
June 30, 2016 | -0.0059M |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
March 31, 2015 | 0.00 |
December 31, 2014 | |
September 30, 2014 | |
March 31, 2014 | 0.0258M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-3.164M
Minimum
Jun 2019
-1.349M
Maximum
Jun 2020
-2.479M
Average
-2.521M
Median
Mar 2020
Free Cash Flow (Quarterly) Benchmarks
Humanigen Inc | -7.059M |
Cantabio Pharmaceuticals Inc | -- |
Affymax Inc | -- |
RVL Pharmaceuticals PLC | -13.11M |
Scopus BioPharma Inc | -1.009M |